Live feed07:46:20·801dSECFilingvia QuantisnowZevra Therapeutics Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Termination of a Material Definitive Agreement, Creation of a Direct Financial Obligation, Regulation FD DisclosureByQuantisnow·Wall Street's wire, on your screen.ZVRA· Zevra Therapeutics Inc.Health CareOriginal source